Mitoxantrone hydrochloride liposome (Zhongnan Hospital)

盐酸米托蒽醌脂质体（武汉大学中南医院）

Report date: 2025/08/29 17:39:25

Base Information

Drug NameMitoxantrone hydrochloride liposome (Zhongnan Hospital)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitorsProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsTopoisomerase II inhibitors

TargetsTopoisomerase IIProto-oncogene serine/threonine-protein kinase Pim-1Hepatitis C virus serine protease, NS3/NS4A

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 3 Clinical

Highest Status in ChinaPhase 3 Clinical

Originator CompaniesZhongnan Hospital Of Wuhan University

China Registration ClassN/A

Develop Information

Active CompaniesZhongnan Hospital Of Wuhan University

Inactive CompaniesN/A

Active IndicationsLeukemia, Myeloid, Acute

Inactive IndicationsN/A

Other Information

ATC CodeN/A